JP Morgan Chase
PAVM icon

JP Morgan Chase’s PAVmed PAVM Stock Holding History

JP Morgan Chase’s Portfolio PAVM Stock Details PAVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1
Closed -$4 – 7791
2025
Q4 		$4 Hold
1
– – ﹤0.01% 7363
2025
Q3 		$8 Hold
1
– – ﹤0.01% 7324
2025
Q2 		$11 Hold
1
– – ﹤0.01% 6978
2025
Q1 		$14 Hold
1
– – ﹤0.01% 7166
2024
Q4 		$12 Hold
1
– – ﹤0.01% 7305
2024
Q3 		$24 Hold
1
– – ﹤0.01% 7236
2024
Q2 		$30 Hold
1
– – ﹤0.01% 7112
2024
Q1 		$78 Hold
1
– – ﹤0.01% 6952
2023
Q4 		$123 Hold
1
– – ﹤0.01% 7102
2023
Q3 		$103 Hold
1
– – ﹤0.01% 6907
2023
Q2 		$102 Hold
1
– – ﹤0.01% 6693
2023
Q1 		$0 Hold
1
– – ﹤0.01% 7098
2022
Q4 		$0 Hold
1
– – ﹤0.01% 6870
2022
Q3 		$0 Hold
1
– – ﹤0.01% 6748
2022
Q2 		$0 Sell
1
-75
-99% -$36.2K ﹤0.01% 6762
2022
Q1 		$45K Buy
76
+16
+27% +$11.9K ﹤0.01% 5833
2021
Q4 		$66K Hold
60
– – ﹤0.01% 5848
2021
Q3 		$229K Sell
60
-2
-3% -$6.31K ﹤0.01% 5164
2021
Q2 		$178K Buy
62
+10
+19% +$23.6K ﹤0.01% 5303
2021
Q1 		$104K Sell
52
-172
-77% -$259K ﹤0.01% 5364
2020
Q4 		$213K Buy
224
+166
+286% +$142K ﹤0.01% 4787
2020
Q3 		$46K Sell
58
-15
-21% -$13.3K ﹤0.01% 4953
2020
Q2 		$69K Buy
+73
New +$73K ﹤0.01% 4707

Other funds holding PAVM

TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase's PAVM Position: Q1 2026 in Review

JP Morgan Chase sold out of PAVmed (PAVM) in Q1 2026, closing a stake of 1 share — an estimated $4 sold.

JP Morgan Chase first reported a position in PAVM in Q2 2020 and held it in 23 quarters. The position peaked at $229K in Q3 2021. 20 funds tracked by Wall St. Rank hold PAVM as of Q1 2026.

  • JP Morgan Chase reported no remaining PAVmed position as of Q1 2026 after selling out during the quarter.
  • JP Morgan Chase sold 1 PAVmed share in Q1 2026, an estimated $4.
  • JP Morgan Chase first reported a position in PAVmed in Q2 2020 and held it in 23 quarters.
  • JP Morgan Chase's PAVmed position peaked at $229K in Q3 2021.
  • 20 funds tracked by Wall St. Rank held PAVmed as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.